Perrigo | PRGO - Ebitda



Perrigo reported $129.1M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
AbbVie USD 4.4B 2.52B Mar/2025
Abbott USD 3.05B 870M Jun/2025
Bayer EUR 236M 3.35B Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Dr.Reddys Laboratories INR 21.74B 989M Jun/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Merck USD 7.74B 625M Mar/2025
Nestle CHF 9.09B 557M Jun/2025
Pacira USD 54.32M 24.98M Jun/2025
Perrigo USD 129.1M 1.9M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Prestige Brands USD 79.65M 28.5M Jun/2025
Reckitt Benckiser GBP 2.66B 733M Dec/2024
Sanofi EUR 1.89B 971M Jun/2025
Supernus Pharmaceuticals USD 41.47M 23.68M Jun/2025
Teva Pharmaceutical Industries USD 1.23B 124M Jun/2025
Xeris Pharmaceuticals USD 8.59M 2.87M Jun/2025
Zoetis USD 1.08B 110M Jun/2025